X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5577) 5577
Publication (576) 576
Book Review (96) 96
Book Chapter (19) 19
Book / eBook (9) 9
Conference Proceeding (8) 8
Dissertation (7) 7
Magazine Article (3) 3
Streaming Video (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (4136) 4136
male (2875) 2875
rats (2402) 2402
humans (1946) 1946
serotonin (1919) 1919
neurosciences (1877) 1877
index medicus (1822) 1822
pharmacology & pharmacy (1721) 1721
receptors, serotonin - metabolism (1237) 1237
female (1041) 1041
serotonin antagonists - pharmacology (1027) 1027
serotonin - metabolism (1020) 1020
psychiatry (935) 935
5-ht (896) 896
rats, sprague-dawley (884) 884
mice (859) 859
receptors, serotonin - drug effects (844) 844
receptors (822) 822
serotonin - pharmacology (750) 750
dose-response relationship, drug (728) 728
brain - metabolism (688) 688
serotonin receptor agonists - pharmacology (686) 686
brain (601) 601
rats, wistar (546) 546
receptor (531) 531
in vitro techniques (518) 518
dopamine (496) 496
adult (471) 471
receptor, serotonin, 5-ht2a - metabolism (465) 465
schizophrenia (457) 457
receptors, serotonin - physiology (453) 453
5-hydroxytryptamine (434) 434
serotonin receptors (427) 427
rat (399) 399
brain - drug effects (397) 397
neurons (389) 389
biochemistry & molecular biology (388) 388
rats, inbred strains (378) 378
clinical neurology (375) 375
ketanserin - pharmacology (375) 375
rat-brain (332) 332
piperazines - pharmacology (330) 330
serotonin - physiology (328) 328
neurology (327) 327
behavior, animal - drug effects (318) 318
disease models, animal (314) 314
depression (310) 310
middle aged (309) 309
indoles - pharmacology (306) 306
article (305) 305
cerebral cortex - metabolism (305) 305
physiology (300) 300
serotonin 5-ht2 receptor antagonists (299) 299
time factors (295) 295
receptor, serotonin, 5-ht2c - metabolism (294) 294
dopamine - metabolism (290) 290
biomedicine (282) 282
binding (280) 280
antipsychotic agents - pharmacology (275) 275
rodents (274) 274
pharmacology (271) 271
research (263) 263
motor activity - drug effects (262) 262
serotonin 5-ht2 receptor antagonists - pharmacology (258) 258
in-vivo (247) 247
kinetics (244) 244
neurons - drug effects (244) 244
analysis (241) 241
prefrontal cortex (240) 240
radioligand assay (240) 240
physiological aspects (239) 239
cells, cultured (238) 238
pharmacology/toxicology (238) 238
piperidines - pharmacology (238) 238
5-ht2 receptors (237) 237
expression (237) 237
amphetamines - pharmacology (235) 235
activation (232) 232
receptors, serotonin, 5-ht2 - metabolism (229) 229
antidepressants (227) 227
ligands (227) 227
structure-activity relationship (223) 223
neurons - metabolism (221) 221
mice, inbred c57bl (218) 218
serotonin 5-ht2 receptor agonists - pharmacology (214) 214
antidepressive agents - pharmacology (213) 213
cell biology (208) 208
serotonin uptake inhibitors - pharmacology (207) 207
signal transduction (202) 202
drugs (200) 200
endocrinology & metabolism (199) 199
drug interactions (198) 198
serotonin 5-ht2 receptor agonists (198) 198
schizophrenia - drug therapy (196) 196
phenols (193) 193
hippocampus - metabolism (192) 192
research article (191) 191
receptors, dopamine d2 - metabolism (186) 186
nervous system (185) 185
ketanserin (184) 184
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5555) 5555
Japanese (87) 87
Russian (20) 20
Chinese (7) 7
French (3) 3
German (3) 3
Polish (3) 3
Hungarian (2) 2
Portuguese (2) 2
Ukrainian (2) 2
Czech (1) 1
Danish (1) 1
Dutch (1) 1
Italian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2008, Volume 134, Issue 7, pp. 2004 - 2013
Background & Aims: Chemotherapy with an anticancer agent generally causes gastrointestinal tract disorders such as vomiting and anorexia, but the mechanism... 
Gastroenterology and Hepatology | SEROTONIN RECEPTOR | GHRELIN LEVELS | SYMPTOMS | MICE | EMESIS | GASTROENTEROLOGY & HEPATOLOGY | STOMACH | Receptor, Serotonin, 5-HT2B - metabolism | Receptor, Serotonin, 5-HT2C - metabolism | Body Weight - drug effects | Drugs, Chinese Herbal - pharmacology | Male | Stomach - metabolism | Drugs, Chinese Herbal - metabolism | Anorexia - physiopathology | Quinolines - pharmacology | Serotonin Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Serotonin 5-HT2 Receptor Antagonists | Chalcones - pharmacology | Dopamine Antagonists - metabolism | Receptors, Ghrelin - metabolism | Indoles - pharmacology | Stomach - innervation | Stomach - drug effects | Drugs, Chinese Herbal - therapeutic use | Flavones - pharmacology | Acylation | Disease Models, Animal | Antineoplastic Agents | Rats | Thiophenes - pharmacology | Anorexia - metabolism | Dopamine Antagonists - therapeutic use | Receptors, Ghrelin - drug effects | Piperazines - pharmacology | Rats, Sprague-Dawley | Vagotomy | Cisplatin | Ghrelin - metabolism | Eating - drug effects | Gastrointestinal Agents - pharmacology | Ghrelin - blood | Animals | Dopamine Antagonists - pharmacology | Aminopyridines - pharmacology | Serotonin - metabolism | Gastrointestinal Agents - therapeutic use | Anorexia - prevention & control | Hesperidin - pharmacology | Protein Binding | Anorexia - chemically induced | Oligopeptides - pharmacology | Gastrointestinal Agents - metabolism | Medicine, Botanic | Medicine, Herbal
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, p. e82407
Background: Serotonin plays a pivotal role in regulating and modulating physiological and behavioral processes in both vertebrates and invertebrates. In the... 
AGONIST-INDEPENDENT ACTIVITY | SEROTONIN RECEPTOR | MOLECULAR-BIOLOGY | CAENORHABDITIS-ELEGANS | DROSOPHILA-MELANOGASTER | MULTIDISCIPLINARY SCIENCES | DIVISION-OF-LABOR | D2-LIKE DOPAMINE-RECEPTOR | DECAPOD CRUSTACEANS | BIOGENIC-AMINE RECEPTORS | HYPOPHARYNGEAL GLAND | Amino Acid Sequence | RNA Isoforms | Receptors, Serotonin, 5-HT2 - chemistry | Humans | RNA, Messenger - genetics | Gene Expression Regulation | Molecular Sequence Data | Serotonin 5-HT2 Receptor Agonists - pharmacology | Phylogeny | Receptors, Serotonin, 5-HT2 - metabolism | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Sequence Analysis, DNA | Bees - physiology | Dose-Response Relationship, Drug | Organ Specificity - genetics | Sequence Alignment | Animals | Receptors, Serotonin, 5-HT2 - genetics | Cloning, Molecular | HEK293 Cells | Female | Gene Order | Neuroimaging | Alternative splicing | Brain | Visual discrimination learning | Transcription | Glands | Nervous system | Biochemistry | Genomes | Biology | Bees | Proteins | Receptors | Phylogenetics | Mianserin | Bioinformatics | Methiothepin | Recombinant | Calcium (intracellular) | Dopamine | Serotonin | Calcium imaging | Pharmacology | Clozapine | Serotonin S2 receptors | Mammals | Gene expression | Exocrine glands | Honey | Vertebrates | Brain research | Insects | 8-Hydroxy-2-(di-n-propylamino)tetralin | Cell lines | Information processing | Epigenetics | Receptor mechanisms | Invertebrates | Division of labor
Journal Article
Nature Neuroscience, ISSN 1097-6256, 05/2010, Volume 13, Issue 5, pp. 622 - 629
Stress and anxiety disorders are risk factors for depression and these behaviors are modulated by corticotrophin-releasing factor receptor 1 (CRFR1) and... 
LOCALIZATION | INTERNALIZATION | CORTICOTROPIN-RELEASING-FACTOR | RAT | DESENSITIZATION | SEROTONIN RECEPTORS | TRAFFICKING | CENTRAL-NERVOUS-SYSTEM | PSD-95 | ENDOCYTOSIS | NEUROSCIENCES | Embryo, Mammalian | Amphetamines - pharmacology | Humans | Receptors, Corticotropin-Releasing Hormone - genetics | Male | Anxiety - drug therapy | Receptors, Serotonin, 5-HT2 - metabolism | Serotonin - pharmacology | Dose-Response Relationship, Drug | Fluorobenzenes - pharmacology | Serotonin 5-HT2 Receptor Antagonists | Transfection | Piperidines - pharmacology | Reaction Time - drug effects | Behavior, Animal - drug effects | Inositol Phosphates - metabolism | Anxiety - metabolism | Cyclic AMP - metabolism | Ionophores - pharmacology | Disease Models, Animal | Hormones - pharmacology | Maze Learning - physiology | Neurons | Cells, Cultured | Anxiety - physiopathology | Monensin - pharmacology | Rats | Behavior, Animal - physiology | Maze Learning - drug effects | Mutation - genetics | Prefrontal Cortex - cytology | Corticotropin-Releasing Hormone - pharmacology | Receptors, Corticotropin-Releasing Hormone - physiology | Animals | Receptors, Serotonin, 5-HT2 - genetics | Serotonin Agents - pharmacology | Signal Transduction - drug effects | Signal Transduction - physiology | Biotinylation - methods | Mice | Serotonin 5-HT2 Receptor Agonists | Endocytosis | Physiological aspects | Cellular signal transduction | Anxiety | Genetic aspects | Research | Genetic regulation
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 12/2005, Volume 25, Issue 49, pp. 11231 - 11238
Serotonin (5-hydroxytryptamine; 5-HT) plays key roles in sleep-wakefulness regulation. Evidence indicates that 5-HT2 receptors are involved mainly in non-rapid... 
Apnea | Sleep | receptors | Serotonin | Knock-out mice | EEG | Depression | Serotonergic | Mice | 5-HT | Respiration | Sleep deprivation | HOMEOSTASIS | ANTAGONIST | PHARMACOLOGICAL CHARACTERIZATION | respiration | mice | PARADOXICAL SLEEP | NEUROSCIENCES | serotonergic | sleep | apnea | serotonin | sleep deprivation | ANIMAL-MODEL | depression | 5-HT2 receptors | knock-out mice | EXPRESSION | MODULATION | REM-SLEEP | Wakefulness - drug effects | Wakefulness - genetics | Adaptation, Physiological - physiology | Male | Sleep Deprivation - genetics | Sleep - genetics | Serotonin Antagonists - pharmacology | Sleep - drug effects | Sleep Deprivation - metabolism | Mice, Knockout | Serotonin Receptor Agonists - pharmacology | Pulmonary Ventilation - genetics | Serotonin 5-HT2 Receptor Antagonists | Receptor, Serotonin, 5-HT2A - physiology | Animals | Receptors, Serotonin, 5-HT2 - genetics | Adaptation, Physiological - genetics | Receptors, Serotonin, 5-HT2 - deficiency | Receptor, Serotonin, 5-HT2A - deficiency | Pulmonary Ventilation - physiology | Wakefulness - physiology | Serotonin 5-HT2 Receptor Agonists | Sleep - physiology | Adaptation, Physiological | Sleep Deprivation | Pulmonary Ventilation | Neurons and Cognition | Neurobiology | Serotonin Agonists | Receptor, Serotonin, 5-HT2A | Life Sciences | Receptors, Serotonin, 5-HT2 | Wakefulness | Serotonin Antagonists | Behavioral | Systems | Cognitive
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2019, Volume 14, Issue 1, p. e0203980
Journal Article
Psychopharmacology, ISSN 0033-3158, 11/2018, Volume 235, Issue 11, pp. 3083 - 3091
Sleep paralysis is a state of involuntary immobility occurring at sleep onset or offset, often accompanied by uncanny “ghost-like” hallucinations and extreme... 
Hypnopompic | Neurosciences | Hypnogogic | Hallucinogenic drugs | Biomedicine | Treatment | Sleep paralysis | Mystical experiences | Hallucinations | Serotonin 2A | Pharmacology/Toxicology | Psychiatry | Ketanserin | EGO-DISSOLUTION | PSYCHIATRY | EGYPTIAN COLLEGE-STUDENTS | HYPOCRETIN-OREXIN | NEUROSCIENCES | GENERAL-POPULATION | SPIRITUAL SIGNIFICANCE | SENSED PRESENCE | IN-VIVO | RECEPTOR ACTIVATION | PHARMACOLOGY & PHARMACY | DIRECT TREATMENT INTERVENTION | MYSTICAL-TYPE EXPERIENCES | Psilocybin - metabolism | Humans | Lysergic Acid Diethylamide - metabolism | Serotonin 5-HT2 Receptor Agonists - adverse effects | Serotonin 5-HT2 Receptor Agonists - pharmacology | Serotonin - pharmacology | Psilocybin - pharmacology | Piperidines - pharmacology | Urea - analogs & derivatives | Urea - metabolism | Sleep - physiology | Serotonin 5-HT2 Receptor Agonists - metabolism | Dopamine - metabolism | Sleep Paralysis - drug therapy | Hallucinations - drug therapy | Hallucinogens - pharmacology | Piperidines - metabolism | Dopamine - pharmacology | Hallucinations - chemically induced | Hallucinogens - metabolism | Hallucinations - metabolism | Neuropharmacology | Serotonin 5-HT2 Receptor Antagonists - pharmacology | Sleep - drug effects | Sleep Paralysis - chemically induced | Serotonin 5-HT2 Receptor Antagonists - metabolism | Serotonin 5-HT2 Receptor Antagonists - therapeutic use | Sleep Paralysis - metabolism | Urea - therapeutic use | Animals | Lysergic Acid Diethylamide - pharmacology | Piperidines - therapeutic use | Serotonin - metabolism | Lysergic Acid Diethylamide - adverse effects | Receptor, Serotonin, 5-HT2A - metabolism | Urea - pharmacology | Receptors | Hallucinations and illusions | Sleep | Serotonin | Research | Drug therapy | Health aspects | Drugs | Dopamine | Lysergic acid diethylamide--LSD | Lysergic acid diethylamide | Visual pathways | Positron emission | Activation | Cortex (visual) | Lysergide | Serotonin S2 receptors | Fear | Chromosome 13 | Anxiety | Paralysis | Psilocybine | Positron emission tomography | Dopamine receptors | Theoretical and Methodological
Journal Article